• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A diagnostic one-step real-time reverse transcription polymerase chain reaction method for accurate detection of influenza virus type A

tetano

Editor, Senior Moderator
Arch Med Sci. 2016 Dec 1;12(6):1286-1292. Epub 2016 Oct 24.
[h=1]A diagnostic one-step real-time reverse transcription polymerase chain reaction method for accurate detection of influenza virus type A.[/h] Behzadi MA[SUP]1[/SUP], Ziyaeyan M[SUP]2[/SUP], Alborzi A[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] Influenza A is known as a public health concern worldwide. In this study, a novel one-step real-time reverse transcription polymerase chain reaction (rtRT-PCR) assay was designed and optimized for the detection of influenza A viruses.
[h=4]MATERIAL AND METHODS:[/h] The primers and probe were designed based on the analysis of 90 matrix nucleotide sequence data of influenza type A subtypes from the GenBank database of the National Center for Biotechnology Information (NCBI). The influenza virus A/Tehran/5652/2010 (H1N1 pdm09) was used as a reference. The rtRT-PCR assay was optimized, compared with that of the World Health Organization (WHO), and its analytical sensitivity, specificity and reproducibility were evaluated. In total, 64 nasopharyngeal swabs from patients with influenza-like illness (ILI) and 41 samples without ILI symptoms were tested for the virus, using conventional cell culture, direct immunofluorescence antibody (DFA) methods, and one-step rtRT-PCR with the designed primer set and probe and the WHO's.
[h=4]RESULTS:[/h] The optimized assay results were similar to the WHO's. The optimized assay results were similar to WHO's, with non-significant differences for 10-10[SUP]3[/SUP] copies of viral RNA/reaction (p > 0.05). It detected 10 copies of viral RNA/reaction with high reproducibility and no cross reactivity with other respiratory viruses. A specific cytopathic effect was observed in 6/64 (9.37%) of the ILI group using conventional culture and DFA staining methods; however, it was not seen in non-ILI. Also, the results of our assay and the WHO's were similar to those of viral isolation and DFA staining.
[h=4]CONCLUSIONS:[/h] Given the high specificity, sensitivity and reproducibility of this novel assay, it can serve as a reliable diagnostic tool for the detection of influenza A viruses in clinical specimens and lab experiments.


[h=4]KEYWORDS:[/h] detection; influenza A virus; one-step real-time polymerase chain reaction

PMID: 27904520 DOI: 10.5114/aoms.2016.62914
[PubMed - in process]
 
Back
Top Bottom